National Cancer Institute; Notice of Meeting, 54990 [2021-21666]

Download as PDF 54990 Federal Register / Vol. 86, No. 190 / Tuesday, October 5, 2021 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors. The meeting will be held as a virtual meeting and is open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (http:// videocast.nih.gov/). A portion of the National Cancer Advisory Board meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended. The intramural programs and projects and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the intramural programs and projects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Advisory Board and NCI Board of Scientific Advisors. Date: December 7, 2021. Closed: 12:00 p.m. to 1:00 p.m. Agenda: Review of intramural program site visit outcomes and the discussion of confidential personnel issues. Open: 1:15 p.m. to 4:45 p.m. Agenda: NCAB Subcommittee Meetings— Subcommittee on Planning and Budget; Ad Hoc Subcommittee on Experimental Therapeutics; and Ad Hoc Subcommittee on Population Science, Epidemiology and Disparities. Place: National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 (Virtual Meeting). Name of Committee: National Cancer Advisory Board and NCI Board of Scientific Advisors. Date: December 8, 2021. Open: 1:00 p.m. to 5:00 p.m. Agenda: Joint meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors, NCI Director’s report and presentations, NCI Board of Scientific Advisors Concepts Review. Place: National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 (Virtual Meeting). VerDate Sep<11>2014 18:56 Oct 04, 2021 Jkt 256001 Name of Committee: National Cancer Advisory Board and NCI Board of Scientific Advisors. Date: December 9, 2021. Open: 1:00 p.m. to 5:00 p.m. Agenda: Joint meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors, NCI Board of Scientific Advisors Concepts Review and presentations. Place: National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 (Virtual Meeting). Contact Person: Paulette S. Gray, Ph.D., Director, Division of Extramural Activities, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, 7th Floor, Room 7W444, Bethesda, MD 20892, 240–276–6340, grayp@ mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: NCAB: https://deainfo.nci.nih.gov/advisory/ ncab/ncabmeetings.htm, BSA: https:// deainfo.nci.nih.gov/advisory/bsa/ bsameetings.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: September 30, 2021. Melanie Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–21666 Filed 10–4–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Cancellation of Meeting Notice is hereby given of the cancellation of the Center for Scientific Review Special Emphasis Panel: Mechanisms of Emotion, Stress and Health, October 25, 2021, 5:00 p.m. to October 25, 2021, 5:30 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 Register on September 28, 2021, FR Doc 2021–21035, 86 FR 53665. This notice is being amended to announce that the meeting is cancelled. Dated: September 30, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–21723 Filed 10–4–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50). Date: November 5, 2021. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Erin E. Gray, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Boulevard, NSC 6152B, Bethesda, MD 20892, 301–402–8152, erin.gray@nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors. Date: November 17, 2021. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Aileen Schulte, Ph.D., Scientific Review Officer, Division of E:\FR\FM\05OCN1.SGM 05OCN1

Agencies

[Federal Register Volume 86, Number 190 (Tuesday, October 5, 2021)]
[Notices]
[Page 54990]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21666]



[[Page 54990]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Cancer 
Advisory Board and NCI Board of Scientific Advisors.
    The meeting will be held as a virtual meeting and is open to the 
public as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting, should notify the Contact Person listed below in 
advance of the meeting. The meeting will be videocast and can be 
accessed from the NIH Videocasting and Podcasting website (http://videocast.nih.gov/).
    A portion of the National Cancer Advisory Board meeting will be 
closed to the public in accordance with the provisions set forth in 
section 552b(c)(6), Title 5 U.S.C., as amended. The intramural programs 
and projects and the discussions could disclose confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the 
intramural programs and projects, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board and NCI Board 
of Scientific Advisors.
    Date: December 7, 2021.
    Closed: 12:00 p.m. to 1:00 p.m.
    Agenda: Review of intramural program site visit outcomes and the 
discussion of confidential personnel issues.
    Open: 1:15 p.m. to 4:45 p.m.
    Agenda: NCAB Subcommittee Meetings--Subcommittee on Planning and 
Budget; Ad Hoc Subcommittee on Experimental Therapeutics; and Ad Hoc 
Subcommittee on Population Science, Epidemiology and Disparities.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Virtual Meeting).

    Name of Committee: National Cancer Advisory Board and NCI Board 
of Scientific Advisors.
    Date: December 8, 2021.
    Open: 1:00 p.m. to 5:00 p.m.
    Agenda: Joint meeting of the National Cancer Advisory Board and 
NCI Board of Scientific Advisors, NCI Director's report and 
presentations, NCI Board of Scientific Advisors Concepts Review.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Virtual Meeting).

    Name of Committee: National Cancer Advisory Board and NCI Board 
of Scientific Advisors.
    Date: December 9, 2021.
    Open: 1:00 p.m. to 5:00 p.m.
    Agenda: Joint meeting of the National Cancer Advisory Board and 
NCI Board of Scientific Advisors, NCI Board of Scientific Advisors 
Concepts Review and presentations.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Virtual Meeting).
    Contact Person: Paulette S. Gray, Ph.D., Director, Division of 
Extramural Activities, National Cancer Institute--Shady Grove, 
National Institutes of Health, 9609 Medical Center Drive, 7th Floor, 
Room 7W444, Bethesda, MD 20892, 240-276-6340, [email protected].

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.
    Information is also available on the Institute's/Center's home 
page: NCAB: https://deainfo.nci.nih.gov/advisory/ncab/ncabmeetings.htm, 
BSA: https://deainfo.nci.nih.gov/advisory/bsa/bsameetings.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 30, 2021.
Melanie Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-21666 Filed 10-4-21; 8:45 am]
BILLING CODE 4140-01-P